Description
In this presentation, Will Eardley delves into the latest developments in hip fracture research, particularly focusing on early surgery, the choice of surgical implants, and relevant studies promoting evidence-based practices in patient care. Eardley begins by emphasizing the ongoing questions surrounding hip fracture treatment and the efficacy of early surgical intervention. He highlights the findings from the "hip ATTACK" trial, which assesses accelerated surgery within six hours versus standard care (within 24 hours), noting no significant difference in mortality or morbidity but indicating benefits like reduced delirium and shorter hospital stays with quicker operations.
Eardley also addresses the debate on using intramedullary nails versus sliding hip screws to treat extracapsular hip fractures. He references a study that suggests higher 30-day mortality associated with intramedullary nails compared to sliding hip screws, stressing the importance of data from large observational studies in guiding clinical decisions. Finally, he discusses the FAITH trial, which compares dynamic and static implants, concluding that neither option shows significant superiority in outcomes, thereby allowing clinicians the flexibility to choose based on patient needs. Eardley's presentation underscores the continuous evolution of hip fracture management and the necessity for a thorough understanding of the current evidence.